Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Compliant Analysis of Patient Samples and Data

NCT: NCT04364503 · ENROLLING_BY_INVITATION

NCT IDNCT04364503
StatusENROLLING_BY_INVITATION
Start Date2018-03-17
Completion2030-08-15
SponsorSequenom, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.

Frequently Asked Questions

What is Compliant Analysis of Patient Samples and Data?

Compliant Analysis of Patient Samples and Data is a clinical trial registered under NCT04364503. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT04364503?

The current status of NCT04364503 (Compliant Analysis of Patient Samples and Data) is: ENROLLING_BY_INVITATION.

When did Compliant Analysis of Patient Samples and Data start?

Compliant Analysis of Patient Samples and Data started on 2018-03-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.